Lower riskMedical device recall · FDA · Published May 21, 2024
BD Alaris System Manager 9601 Software Issue: Wireless Data Transmission Problems
CareFusion recalls BD Alaris System Manager REF 9601 software versions 12.5.1 due to wireless data transmission issues with compatible BD Alaris PC Units.
“BD Alaris System Manager 9601 Software Issue: Wireless Data Transmission Problems.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/55038-bd-alaris-system-manager-9601-software-issue-wireless-data-transmission. Based on FDA recall #Z-2262-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2262-2024%22&limit=1).
CareFusion 303, Inc. is recalling BD Alaris System Manager REF: 9601 due to a software issue that may prevent the PC unit from connecting to the server, impacting wireless data transmission. The Food and Drug Administration announced this Class II recall on May 21, 2024.
How to tell if you have it
BD Alaris System Manager REF: 9601
UDI: 10885403960123
Software versions 12.5.1
The hazard
Due to a software issue, the PC unit may not connect to the server which could impact wireless data transmission to and from the server.
Context
GovInfoNow's records show CareFusion 303, Inc. has had 64 other recalls on record since June 12, 2017. Other recent recalls of similar products include BD Pyxis Mini Main REF 349 Medication Cabinet (April 30, 2026) and CareFusion labeling issue (Feb. 11, 2026).
How to tell if you have this one
Check for BD Alaris System Manager REF 9601 software version 12.5.1 on compatible BD Alaris PC Units. The unique device identifier (UDI) is 10885403960123.
Brand
CareFusion
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Software Version
Verify the software version on your BD Alaris PC Unit to see if it is 12.5.1.
Where it went and when
Where it was distributed
Distributed nationwide; the notice names 43 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT DC, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, SD, TN, TX, UT, VA, WA, WI.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, Wisconsin.
Recall timeline
FDA published this recall 50 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-2262-2024 (May 21, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2262-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.